You are here

Company Monitoring Page for Boehringer-Ingelheim

latest headlines for company on cafepharma

FDA approves Boehringer's once-a-day inhaler drug

Yahoo/AP

Thu, 07/31/14 - 03:58 pm

Tags:

FDA, Boehringer Ingelheim, Striverdi Respimat, COPD

J&J builds 9-month supply of Doxil with creative problem solving

Fierce Pharma

Fri, 07/25/14 - 05:59 pm

Tags:

JNJ, Boehringer Ingelheim, Doxil, drug shortage, Janssen, ovarian cancer

Did Boehringer Ingelheim Withhold Pradaxa Data From Regulators?

WSJ Online

Wed, 07/23/14 - 06:29 pm

Tags:

Pradaxa, Boehringer Ingelheim

Boehringer cancer drug effective in mid-stage trial

Reuters

Tue, 07/8/14 - 10:26 am

Tags:

Boehringer Ingelheim, acute myeloid leukemia, volasertib

NICE backs thousands more scripts for clot-fighters Pradaxa, Xarelto, and Eliquis

Fierce Pharma

Thu, 06/19/14 - 10:36 am

Tags:

NICE, Pradaxa, Xarelto, bloodthinners, Eliquis, Bayer, JNJ, Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim

FirstWord List: Top 15 pharma and lead product dependency

First Word Pharma

Mon, 06/9/14 - 10:35 am

Tags:

Teva, AbbVie, Boehringer Ingelheim, GSK, Sanofi, Amgen, Eli Lilly, JNJ, AstraZeneca, Roche, Novartis, Merck, Pfizer, Takeda, Bristol-Myers Squibb

Boehringer Ingelheim to sell US injectable generics business to Hikma for up to $300 million

First Word Pharma

Wed, 05/28/14 - 10:07 am

Tags:

Boehringer Ingelheim, Hikma, injectables, M&A

Boehringer to settle lawsuits against blockbuster drug for $650 mln

Yahoo/Reuters

Wed, 05/28/14 - 09:42 am

Tags:

Boehringer Ingelheim, Pradaxa

Novartis, Boehringer vie for COPD market share with combo meds

Fierce Biotech

Thu, 05/22/14 - 11:57 am

Tags:

COPD, Novartis, Boehringer Ingelheim, LAMA/LABA

Boehringer Ingelheim to Make Clinical Trial Data Available

PharmTech

Sat, 05/17/14 - 10:18 am

Tags:

Boehringer Ingelheim

Biotech Stock Mailbag: Previewing InterMune's Big Week Ahead

TheStreet.com

Fri, 05/16/14 - 10:07 am

Tags:

InterMune, IPF, idiopathic pulmonary fibrosis, Boehringer Ingelheim, pirfenidone, nintedanib

Show me the money: Which drugs made the top 10 list on upfront deals?

Fierce Biotech

Mon, 05/12/14 - 09:36 am

Warfarin's Loss is Johnson & Johnson's Gain

Motley Fool

Mon, 04/21/14 - 04:20 pm

Tags:

JNJ, bloodthinners, Warfarin, Pradaxa, Xarelto, Boehringer Ingelheim

Eli Lilly/ Boehringer Drug Under FDA Review

Yahoo/Zacks.com

Tue, 04/15/14 - 04:49 pm

Tags:

FDA, Eli Lilly, Boehringer Ingelheim, Trajenta, empagliflozin, diabetes, type 2 diabetes

Boehringer 2013 profit up on Pradaxa sales, cost cuts

Reuters

Tue, 04/15/14 - 10:37 am

Tags:

earnings, Boehringer Ingelheim

Boehringer Ingelheim's Oral Anticoagulant Gains New Indication

Forbes

Mon, 04/7/14 - 12:57 pm

Tags:

Boehringer Ingelheim, anticlotting, Pradaxa, deep venous thrombosis, DVT, pulmonary embolism

Boehringer, Lilly Diabetes Drug Wins EU Panel’s Backing

Bloomberg

Fri, 03/21/14 - 09:41 am

Tags:

Jardiance, diabetes, Boehringer Ingelheim, Eli Lilly, Europe

InterMune Rises on Takeover Rumour

Yahoo/Zacks.com

Mon, 03/10/14 - 05:05 pm

Tags:

M&A, InterMune, Sanofi, Esbriet, Boehringer Ingelheim, Novartis

Boehringer Ingelheim reports positive phase 3 SVR12 results in HCV/HIV co-infected patients treated with faldaprevir

Pharmabiz

Sat, 03/8/14 - 10:49 am

Tags:

SVR12, Boehringer Ingelheim, HCV, HIV, hepatitis, hepatitis C

What Does This Rejection Mean for Eli Lilly?

Motley Fool

Fri, 03/7/14 - 09:24 am

Tags:

Eli Lilly, FDA, empagliflozin, Boehringer Ingelheim

Pages

last 30 twitter posts